These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12724490

  • 1. Environmental lead exposure and chronic renal disease.
    Owda AK, Alam MG, Shah SV.
    N Engl J Med; 2003 May 01; 348(18):1810-2; author reply 1810-2. PubMed ID: 12724490
    [No Abstract] [Full Text] [Related]

  • 2. Increased body lead burden--cause or consequence of chronic renal insufficiency?
    Marsden PA.
    N Engl J Med; 2003 Jan 23; 348(4):345-7. PubMed ID: 12540649
    [No Abstract] [Full Text] [Related]

  • 3. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL, Lin-Tan DT, Hsu KH, Yu CC.
    N Engl J Med; 2003 Jan 23; 348(4):277-86. PubMed ID: 12540640
    [Abstract] [Full Text] [Related]

  • 4. Environmental lead exposure and chronic renal disease.
    Elinder CG, Alvestrand A.
    N Engl J Med; 2003 May 01; 348(18):1810-2; author reply 1810-2. PubMed ID: 12728912
    [No Abstract] [Full Text] [Related]

  • 5. [Does lead cause renal damage? Surprising results published in a respected journal].
    Elinder CG.
    Lakartidningen; 2003 May 08; 100(19):1736. PubMed ID: 12800302
    [No Abstract] [Full Text] [Related]

  • 6. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D, Mondaini G, Ravera F, Minisci E, Albertazzi V, Arletti S, Mori G, Ballestri M, Piattoni J, Cappelli G.
    G Ital Nefrol; 2007 May 08; 24 Suppl 38():76-9. PubMed ID: 17922453
    [Abstract] [Full Text] [Related]

  • 7. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL, Lin-Tan DT, Li YJ, Chen KH, Huang YL.
    Am J Med; 2006 Aug 08; 119(8):707.e1-9. PubMed ID: 16887418
    [Abstract] [Full Text] [Related]

  • 8. Environmental lead exposure and chronic renal disease.
    Lopes AA, Port FK.
    N Engl J Med; 2003 May 01; 348(18):1810-2; author reply 1810-2. PubMed ID: 12728911
    [No Abstract] [Full Text] [Related]

  • 9. Managing end-stage renal disease.
    J Occup Med; 1991 May 01; 33(5):584. PubMed ID: 1908008
    [No Abstract] [Full Text] [Related]

  • 10. Chronic industrial exposure to lead in 63 subjects. II. Evaluation of chelation therapy.
    Strickland GT, Hwang YF, Chang NK, Blackwell RQ.
    Southeast Asian J Trop Med Public Health; 1976 Dec 01; 7(4):569-74. PubMed ID: 828980
    [Abstract] [Full Text] [Related]

  • 11. The need for vigilance: the persistence of lead poisoning in children.
    Florin TA, Brent RL, Weitzman M.
    Pediatrics; 2005 Jun 01; 115(6):1767-8. PubMed ID: 15930242
    [No Abstract] [Full Text] [Related]

  • 12. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S, Chaivisuth B, Siriratanapreuk S, Padungtod C, Pleubreukan R, Boonnark T, Worahan S, Bhumiratanarak P, Chomchai C.
    J Med Assoc Thai; 2002 Aug 01; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL.
    Nephrol Dial Transplant; 2007 Oct 01; 22(10):2924-31. PubMed ID: 17556414
    [Abstract] [Full Text] [Related]

  • 14. [Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability (author's transl)].
    Yver L, Maréchaud R, Picaud D, Touchard G, d'Eyzac AT, Matuchansky C, Patte D.
    Nouv Presse Med; 1978 May 06; 7(18):1541-3. PubMed ID: 97624
    [Abstract] [Full Text] [Related]

  • 15. Failure of chelation therapy in lead nephropathy.
    Germain MJ, Braden GL, Fitzgibbons JP.
    Arch Intern Med; 1984 Dec 06; 144(12):2419-20. PubMed ID: 6439141
    [Abstract] [Full Text] [Related]

  • 16. Chelation therapy in lead nephropathy questioned.
    Sawyer HJ.
    Arch Intern Med; 1985 Oct 06; 145(10):1927. PubMed ID: 3929710
    [No Abstract] [Full Text] [Related]

  • 17. Improving behavior of lead-exposed children: micronutrient supplementation, chelation, or prevention.
    Chen A, Rogan WJ.
    J Pediatr; 2005 Nov 06; 147(5):570-1. PubMed ID: 16291342
    [No Abstract] [Full Text] [Related]

  • 18. [Lead (author's transl)].
    Tesink J.
    Tijdschr Diergeneeskd; 1972 Mar 01; 97(5):317-26. PubMed ID: 4135079
    [No Abstract] [Full Text] [Related]

  • 19. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
    Bădulici S, Chirilă M.
    Rom J Intern Med; 1992 Mar 01; 30(3):211-5. PubMed ID: 1475600
    [Abstract] [Full Text] [Related]

  • 20. Reversible hypothyroidism with EDTA chelation therapy in a patient with elevated lead burden and chronic renal insufficiency.
    Lin JL, Shih FC.
    Nephrol Dial Transplant; 1997 Feb 01; 12(2):364-5. PubMed ID: 9132667
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.